On May 18, 2010
Big Pharma’s Romance With Biotech Still Smolders, Despite Its Cold Shoulder to OSI
OSI Pharmaceuticals (OSIP) fought off a $3.5 billion hostile takeover attempt by Astellas Pharma and shopped around for another suitor, so many investors were surprised to see Astellas win in the end.
No tags for this post.
0 Comments